Specifically, basal-like tumors mimicked HER2-0 breast cancers; non-basal-like tumors (primarily the HER2-enriched, LAR and MC1/MC2 subtypes) were similar to HER2-positive breast cancers and were enriched in Chinese. Here, ERBB2 is linked to breast carcinoma.